137 related articles for article (PubMed ID: 14512301)
21. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
[TBL] [Abstract][Full Text] [Related]
22. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
[TBL] [Abstract][Full Text] [Related]
23. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
Nikolsky E; Dangas GD
Semin Thromb Hemost; 2004 Jun; 30(3):305-14. PubMed ID: 15282653
[TBL] [Abstract][Full Text] [Related]
25. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
[TBL] [Abstract][Full Text] [Related]
26. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
27. Lepirudin use in a neonate with heparin-induced thrombocytopenia.
Nguyen TN; Gal P; Ransom JL; Carlos R
Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954
[TBL] [Abstract][Full Text] [Related]
28. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
29. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin.
Veach SA; Franks AM; Allan MC
Pharmacotherapy; 2007 May; 27(5):760-5. PubMed ID: 17461712
[TBL] [Abstract][Full Text] [Related]
30. Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.
Mueller SW; MacLaren R; Fish DN; Kiser TH
Ann Pharmacother; 2009 Jul; 43(7):1360-5. PubMed ID: 19584380
[TBL] [Abstract][Full Text] [Related]
31. Update in hematology: heparin-induced thrombocytopenia and bivalirudin.
Augoustides JG
J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):371-5. PubMed ID: 21316987
[TBL] [Abstract][Full Text] [Related]
32. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.
Cochran K; DeMartini TJ; Lewis BE; O Brien J; Steen LH; Grassman ED; Leya F
J Invasive Cardiol; 2003 Nov; 15(11):617-21. PubMed ID: 14608129
[TBL] [Abstract][Full Text] [Related]
33. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
34. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
35. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
36. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
37. Risk of anaphylaxis after reexposure to intravenous lepirudin in patients with current or past heparin-induced thrombocytopenia.
Cardenas GA; Deitcher SR
Mayo Clin Proc; 2005 Apr; 80(4):491-3. PubMed ID: 15819285
[TBL] [Abstract][Full Text] [Related]
38. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
39. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
[No Abstract] [Full Text] [Related]
40. The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery.
Sun Y; Greilich PE; Wilson SI; Jackson MR; Whitten CW
Anesth Analg; 2001 Feb; 92(2):344-6. PubMed ID: 11159229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
